Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$536.87 USD

536.87
1,636,065

+5.01 (0.94%)

Updated Jul 10, 2024 04:00 PM ET

After-Market: $536.96 +0.09 (0.02%) 5:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Mark Vickery headshot

Top Stock Reports for Amgen, FedEx & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Amgen (AMGN), FedEx (FDX) and Thermo Fisher (TMO).

    Thermo Fisher Scientific Buys IntegenX, Widens HID Suite

    Thermo Fisher Scientific (TMO) forges ahead with initiatives to strengthen its hold in the high-potential human identification market.

      Thermo Fisher Grows on New Buyouts Amid Tough Competition

      Thermo Fisher's (TMO) acquisition of FEI Company already adds capabilities to its analytical instruments portfolio. Also, solid cash in hand enables the company to yield fat returns to investors.

        Thermo Fisher (TMO) Q4 Earnings Beat on Growth in All Lines

        Thermo Fisher (TMO) registers a solid international performance in Q4 with strong year-over-year growth in the Asia-Pacific and the emerging markets of China, South Korea and the Middle East.

          Thermo Fisher (TMO) Beats on Q4 Earnings & Sales Estimates

          Thermo Fisher (TMO) rides high on strength in all segments in Q4.

            Why Earnings Season Could Be Great for Thermo Fisher (TMO)

            Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

              Can Thermo Fisher's (TMO) Product Portfolio Up Q4 Earnings?

              Thermo Fisher (TMO) already derives synergies from the acquisition of FEI that largely adds capabilities to its analytical instruments portfolio.

                Illumina (ILMN) Ties Up With Thermo Fisher for Ion AmpliSeq

                Illumina (ILMN) consistently tries to enhance NGS platform.

                  Sheraz Mian headshot

                  Are Interest Rates Really Going Up?

                  The odds of interest rates going up meaningfully are not as far-fetched as many likely in the market believe.

                    Pacific Biosciences Hurt by Competition in Niche Markets

                    Pacific Biosciences (PACB) faces cutthroat competition in the niche space. Also, sluggishness in the European markets is a concern.

                      Mark Vickery headshot

                      Top Research Reports for Microsoft, Intel & UnitedHealth

                      Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Intel (INTC) and UnitedHealth (UNH).

                        Thermo Fisher Buys Phenom-World, Aids Analytical Instruments

                        On completion of Phenom-World purchase, Thermo Fisher (TMO) plans to integrate the business into its Analytical Instruments segment.

                          Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings?

                          AngioDynamics (ANGO) to gain from solid product portfolio and demand for Solero MTA system. However, unfavorable estimates are a concern.

                            Global In Vitro Diagnostic Market Booms: Stocks in Focus

                            With the emergence of complex and transmittable diseases worldwide, In Vitro Diagnostic within the MedTech space is currently in the spotlight.

                              IDEXX Laboratories (IDXX) Q3 Earnings Beat, Revenues Miss

                              IDEXX Laboratories (IDXX) rides high on strength in Companion Animal Group business in Q3. Moreover, a raised guidance buoys optimism.

                                Luminex (LMNX) Tops Q3 Earnings, Meets Revenue Estimates

                                Luminex's (LMNX) third quarter saw a strong top line, solid cash flow as well as profits in Q3. The company's Assay business is likely to drive growth over the long term.

                                  Thermo Fisher (TMO) Q3 Earnings & Sales Top, Guidance Up

                                  On solid third-quarter performance, a favorable foreign exchange environment and the recently closed acquisition of Patheon, Thermo Fisher (TMO) has raised its full-year 2017 guidance.

                                    Thermo Fisher (TMO) Beats on Q3 Earnings & Sales Estimates

                                    Thermo Fisher (TMO) rides high in Q3 banking on its analytical instruments segment in particular.

                                      MedTech Stocks (BAX, VAR, TMO, LH) Earnings Preview: What You Should Know

                                      The Medical Product space has been a precarious game for the Republicans since day one, courtesy of President Trump's repeated failure to repeal and replace Obamacare.

                                        PetMed (PETS) Tops Q2 Earnings & Sales Estimates, Margins Up

                                        The year-over-year rise in earnings of PetMed (PETS) was driven by an increase in sales and improved margins.

                                          Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

                                          Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

                                            Why Thermo Fisher (TMO) Might Surprise This Earnings Season

                                            Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                                              Henry Schein (HSIC) Q3 Earnings to Show Growth in All Lines

                                              Henry Schein (HSIC) likely to gain on strength across all business segments in Q3.

                                                What's in Store for Penumbra (PEN) Stock in Q3 Earnings?

                                                Penumbra (PEN) is expected to gain from strong performance by its neuro and peripheral vascular arms in Q3.

                                                  Can Companion Animal Group Drive IDEXX's (IDXX) Q3 Earnings?

                                                  IDEXX Laboratories (IDXX) is poised to gain from strength in its Companion Animal Group business in Q3.